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Palmitoylation is emerging as an important and dynamic reg-
ulator of ion channel function; however, the specificity with
which the large family of acyl palmitoyltransferases (zinc finger
Asp-His-His-Cys type-containing acyl palmitoyltransferase
(DHHCs)) control channel palmitoylation is poorly understood.
We have previously demonstrated that the alternatively spliced
stress-regulated exon (STREX) variant of the intracellular
C-terminal domain of the large conductance calcium- and volt-
age-activated potassium (BK) channels is palmitoylated and tar-
gets the STREX domain to the plasmamembrane. Using a com-
bined imaging, biochemical, and functional approach coupled
with loss-of-function (small interfering RNA knockdown of
endogenous DHHCs) and gain-of-function (overexpression of
recombinant DHHCs) assays, we demonstrate that multiple
DHHCs control palmitoylation of the C terminus of STREX
channels, the association of the STREX domain with the plasma
membrane, and functional channel regulation. Cysteine resi-
dues 12 and 13 within the STREX insert were the only endog-
enously palmitoylated residues in the entire C terminus of the
STREX channel. Palmitoylation of this dicysteine motif was
controlled by DHHCs 3, 5, 7, 9, and 17, although DHHC17
showed the greatest specificity for this site upon overexpression
of the cognate DHHC. DHHCs that palmitoylated the channel
also co-assembled with the channel in co-immunoprecipitation
experiments, and knockdown of any of these DHHCs blocked
regulation of the channel by protein kinase A-dependent phos-
phorylation. Taken together our data reveal that a subset of
DHHCs controls STREX palmitoylation and function and sug-
gest that DHHC17 may preferentially target cysteine-rich
domains. Finally, our approach may prove useful in elucidating
the specificity ofDHHCpalmitoylation of intracellular domains
of other ion channels and transmembrane proteins.
S-Palmitoylation, the reversible addition of 16-carbon satu-
rated palmitic acid to intracellular cysteine residues through a
labile thioester linkage (1–5), is emerging as an important
dynamic and potent determinant of ion channel function.
Palmitoylation controls cell surface expression and regulation
of many ligand-gated ion channels, including -amino-3-hy-
droxyl-5-methyl-4-isoxazole-propionate (6), N-methyl-D-as-
partate (7), Kainate (8), P2X7 (9), and-aminobutyric acid, type
A (10–12). Palmitoylation also controls the function of voltage-
gated calcium (13–15), sodium (16), and potassium (17–19) as
well as other channels such asAQP4 (20). For example, inKv1.1
potassium channels palmitoylation controls voltage dependence
(18), and in the stress-regulated exon (STREX)3 splice variant of
large conductance calcium- and voltage-activated potassium (BK)
channels, palmitoylation determines channel regulation by pro-
tein phosphorylation (19). However, although functional insights
into ion channel regulation by protein palmitoylation are begin-
ning to emerge, the control of channel palmitoylation is poorly
understood, as for other palmitoylated proteins (21).
Protein palmitoylation is controlled by the balance of palmi-
toyl acyltransferases and palmitoyl thioesterases (1–5). Re-
cently the zinc finger DHHC (Asp-His-His-Cys) type-contain-
ing protein family has emerged as a large family of palmitoyl
acyltransferases with 23 members in the mouse and human
genomes (22, 23). Previous studies have implicated the rela-
tively promiscuous palmitoyltransferase DHHC3 (also known
as Golgi-specific DHHC zinc finger protein, GODZ) in palmi-
toylating some ligand-gated ion channels (6, 7, 10, 12). How-
ever, the role of DHHC3 or other DHHCs in controlling palmi-
toylation of other ion channels, including BK channels, is not
known. Furthermore, whether different DHHCs display speci-
ficity for palmitoylating individual ion channels has not been
examined systematically. Elucidation of such DHHC-substrate
relationships would provide significant insight into both the
functional role of ion channel palmitoylation and the specificity
of DHHCs for diverse target proteins.
We have previously demonstrated that a dicysteine motif
(Cys12-Cys13) within the alternatively spliced STREX insert of
the intracellular C terminus of BK channels (see Fig. 1) is pal-
mitoylated and targets the C terminus to the plasmamembrane
in the absence of the transmembrane domains (19). In this
manuscript, we have thus asked which DHHCs are responsible
for palmitoylation of the STREXdomain of the BK channel.We
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took advantage of the robust endogenous palmitoylation of
STREX channels in human embryonic kidney 293 (HEK293)
cells as an assay system to systematically exploit both loss and
gain of function approaches, through siRNA-mediated knock-
down of endogenous DHHCs and overexpression of murine
recombinant DHHCs, respectively, to interrogate the role of
individual DHHCs in controlling STREX palmitoylation. In
initial assays we exploited an imaging screen based on the
palmitoylation-dependent plasma membrane localization of
the intracellular STREX domain of the BK channel in HEK293
cells (19). Our data represent the first systematic analysis of the
contribution of individual DHHCs in controlling palmitoyla-
tion of a voltage-gated ion channel. These studies reveal that
multiple endogenousDHHCs control palmitoylation of STREX
and that DHHC17 has the highest selectivity for the STREX
Cys12-Cys13 motif. Furthermore, we demonstrate that the
DHHCs that regulate STREX palmitoylation can also assemble
as a complex with the channel and determine the regulation of
STREX channels by protein kinase A (PKA) phosphorylation.
EXPERIMENTAL PROCEDURES
Channel Constructs—The generation of full-length, C-termi-
nal, and CRD epitope-tagged constructs of the STREX and
ZERO variants of the murine BK channel has been described
(19). All mutagenesis was performed using QuikChange
mutagenesis (Stratagene) with constructs fully sequenced on
both strands to verify sequence integrity.
Cell Culture, Transfection, and RNA Extraction—HEK293
cells were maintained in DMEM containing 10% fetal calf
serum in a humidified atmosphere of 95% air, 5% CO2 at 37 °C.
The cells were passaged every 3–7 days using 0.25% trypsin in
Hanks’ buffered salt solution containing 0.1% EDTA. For RNA
extraction or biochemical studies, the cells were grown in 24- or
6-well plates, respectively. For electrophysiological or imaging
assays, the cells were plated on glass coverslips within 6-well
plates. Twenty-four hours prior to the experiment, the cells
were washed, and medium was replaced with DMEM contain-
ing ITS serum replacement (Sigma). The cells were transiently
transfected at 40–60% confluence using Lipofectamine 2000
(Invitrogen) or FuGENE-HD (Roche Applied Science). For
RNA interference, siRNAs were predesigned and supplied by
Qiagen. The knockdown of DHHCs was performed in HEK293
cells by using two siRNAs (10–20 nM of each siRNA) for each
gene. siRNA transfection was performed using HiperFect (Qia-
gen), essentially as described by the manufacturer. The respec-
tive cDNA was transfected 30 min after the completion of
siRNA transfection. RNA extraction was carried out 48–72 h
post-siRNA transfection using a High Pure RNA isolation kit
(Roche Applied Science) according to the manufacturer’s proto-
cols. In all of the imaging and biochemical assays siRNA knock-
down of DHHCs was monitored in parallel in each independent
experiment. Independent experiments were conducted a mini-
mum of three times in triplicate. The palmitoylation inhibitor
2-bromopalmitate (Sigma) was made as a fresh 100 mM stock in
Me2SO and applied at a final concentration of 100M overnight.
Quantitative Real Time PCR—cDNA was synthesized from
the total mRNA of each DHHC knockdown sample using a
Transcriptor High Fidelity cDNA synthesis kit (Roche Applied
Science) as described by the manufacturer. The efficiency of
knockdown of eachDHHCat themRNA level was analyzed using
SYBR Green JumpStart Taq Ready Mix (Sigma) in a 25-l total
volume reaction on an ABIPrism 7000 real time PCR machine.
Approximately 50–75 ng of cDNA was used per reaction with
primersat0.2Mfinal concentrations.The internal referencecon-
trol was endogenous -actin detected using Qiagen primer set
AT01680476. All of the reactions were performed in triplicate.
Cyclingconditionswere50 °C for2min, 95 °C for10min, followed
by 40 cycles of 95 °C for 15 s, and then 60 °C for 1 min. All of the
primers were previously validated with efficiencies calculated to
be within 0.1 of the control using the equation e 10(1/slope) 1.
The percentage of mRNA remaining was calculated using the
equation %mRNA remaining 2Ct 100.
Imaging—Briefly, the cells were plated on glass coverslips,
transfected as above, and fixed 48 h after transfection except for
experiments in Fig. 4 where cells were fixed 24 h post-transfec-
tion. The cells were first washed twice with PBS (Invitrogen)
and then fixedwith ice-cold 4%paraformaldehyde in PBS for 15
min at room temperature. The cells were washed three times
with ice-cold PBS and quenched with 50 mM NH4Cl in PBS for
10 min. The cells were washed three times in ice-cold PBS
before mounting on microscope slides using Mowiol. The cells
were initially analyzed under epifluorescence using an inverted
Nikon Eclipse 2000microscope using a 100 oil objective lens.
High power confocal images were acquired on a Zeiss LSM510
laser scanning microscope, using a 63 oil Plan Apochromat
(NA 1.4) objective lens, in multi-tracking mode to minimize
channel cross-talk. For each independent cell transfection,
three or four coverslips/6-well cluster plate were analyzed for
each construct. For each coverslip three to five random fields of
view were analyzed to determine the number of transfected
cells with plasma membrane localization of the respective
fusion protein. The average percentage of transfected cells from
each well was then determined for each independent transfec-
tion (experiment) and normalized to the corresponding wild
type STREX control (membrane expression was typically
observed in 95% of transfected wild type STREX fusion pro-
teins). The majority of experiments were performed blind. In
addition, a random subset of cells was also analyzed by quanti-
fying the relative peripheral membrane expression compared
with the “intracellular” (cytoplasm nucleus) expression using
ImageJ. The ratio of membrane/intracellular fluorescence was
determined and normalized to control treated cells assayed in
the same experiment under identical conditions. There was no
qualitative difference between these approaches. As such all of
the data are expressed as percentages of the respective control
means S.E. for N independent experiments, where nmin-
imum total number of cells analyzed across experiments for
each construct/treatment.
Palmitoylation Assays, Pulldowns, and Western Blotting—
CSS-palm prediction was performed using the published CSS-
palm v2.0 palmitoylation algorithm (24).
[3H]Palmitic Acid Incorporation—HEK293 cells were tran-
siently transfected in 6-well cluster dishes ( 3 106 cells/well)
with the HA-tagged constructs as indicated in the respective
figure legends. Forty-eight hours post-transfection, the cells
were washed, and 1 ml of fresh DMEM containing 10 mg/ml
DHHC Palmitoylation of BK Channels
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fatty acid free bovine serum albumin was added for 30 min at
37 °C. The cells were incubated in DMEM/bovine serum albu-
min containing 0.5mCi/ml [3H]palmitic acid (PerkinElmer Life
Sciences) for 4 h at 37 °C, and then the medium containing the
free label was removed. The cells were lysed in 150mMNaCl, 50
mM Tris-Cl, 1% Triton X-100, pH 8.0, and centrifuged, and
channel fusion proteins were captured using magnetic
microbeads coupled to HA/GFP antibody (MACSTM epitope
tag isolation kits; Miltenyi Biotech). After washing columns
with 150 mM NaCl, 1% Nonidet P-40, 0.5% deoxycholate, 0.1%
SDS, 50 mM Tris-Cl, pH 8.0, followed by washes with 50 mM
Tris-Cl, pH 7.5, the captured proteins were eluted in SDS-
PAGE sample buffer (50 mM Tris-Cl, pH 6.8, 5 mM dithiothre-
itol, 1% SDS, 1 mM EDTA, 0.005% bromphenol blue, 10% glyc-
erol) prewarmed to 95 °C. The recovered samples were
separated by SDS-PAGE, transferred to nitrocellulose mem-
branes, and probed with either a monoclonal GFP antibody
(Clontech; 1:3000) or polyclonal HA antibody (Zymed Labora-
tories Inc.; 1:1000). A duplicate membrane was dried and
exposed to light-sensitive film at80 °C using a Kodak Biomax
transcreen LE (Amersham Biosciences). Co-immunoprecipita-
tion experiments were performed essentially as described using
the magnetic microbeads and antibodies as above.
Electrophysiological Assays—Single channel current record-
ings were performed in the inside-out configuration of the
patch clamp technique at room temperature (20–24 °C). The
pipette solution (extracellular) contained 140 mM NaCl, 5 mM
KCl, 1 mM CaCl2, 2 mM MgCl2, 20 mM glucose, 10 mM HEPES,
pH7.4. The bath solution (intracellular) contained 140mMKCl,
5 mM NaCl, 2 mM MgCl2, 1 mM 1,2-bis(o-aminophe-
noxy)ethane-N,N,N	,N	-tetraacetic acid, 30mMglucose, 10mM
HEPES, 1 mM ATP, pH 7.3, with free calcium [Ca2]i buffered
to 0.1 M, unless indicated otherwise. Channel activity was
determined during 60-s depolarizations to 40 mV. Data
acquisition and voltage protocols were controlled by an Axo-
patch 200B amplifier and pCLAMP9 software (Axon Instru-
ments Inc., Foster City, CA). All of the recordingswere sampled
at 10 kHz and filtered at 2 kHz. Channel activity was allowed to
stabilize for at least 10min after patch excision before the addi-
tion of drugs. The catalytic subunit of PKA (PKAc) was from
Promega (Madison, WI). Single-channel open probability (Po)
was derived from single-channel analysis using WINEDR (ver-
sion 2.3.9; Dempster, J., University of Strathclyde, Strathclyde,
UK). To determine the mean percentage of change in channel
activity after a treatment, mean Po or N*Po was measured
immediately before and 10 min after the respective drug appli-
cation. The effect of cAMP and/or PKAc on channel activity
was typically maximal by5 min and remained stable over the
next 10–30 min following application to inside-out patches.
The effect of PKA-mediated phosphorylation was abolished in
the absence ofMg-ATP and prevented using the PKA inhibitor
PKI5–24 (data not shown and see Refs. 19 and 25–27).
Statistical Analysis—All of the data are presented as the
means  S.E. with N  number of independent experiments
and n number of individual cells analyzed in imaging assays.
The data were analyzed by analysis of variance with post-hoc
Dunnett’s test or using a nonparametric Kruskal-Wallis test as
appropriate with the significance set at p
 0.05.
RESULTS
Cysteine Residues within STREX Are the Only Endogenously
Palmitoylated Residues in the Entire C Terminus of BK
Channels—Expression of the entire intracellular C-terminal
domain of the STREX splice variant of the murine BK channel
as a HA- or GFP epitope-tagged construct (STREX-Cterm; Fig.
1a) in HEK293 cells resulted in robust palmitoylation (Fig. 1b)
by endogenous palmitoyltransferases (DHHCs) and expression
at the plasma membrane in the absence of the transmembrane
domains (Fig. 1, c and d). We have previously demonstrated
that the di-cysteine motif at amino acid positions 12 and 13
within the STREX insert is essential for this membrane local-
ization and can be conferred by expression of the cysteine-rich
domain (CRD) alone, which includes STREX and the immedi-
ately upstream heme-binding domain (19). In accordance with
this, mutation of both cysteines to alanine (C12A/C13A) abol-
ished palmitoylation of STREX-Cterm by endogenous DHHCs
(Fig. 1b) as well as plasma membrane localization (Fig. 1d). In
the C12A/C13A palmitoylation-deficient mutants, the fusion
protein was robustly expressed as for wild type (Fig. 1b) but
displayed a largely nuclear and/or cytoplasmic cellular distribu-
tion (Fig. 1c). Plasma membrane localization of the STREX C
terminus, or CRD, was also abolished by preincubation of cells
with the palmitoylation inhibitor 2-bromopalmitate (28, 29)
(Fig. 1d). Furthermore, expression of the ZERO variant C ter-
minus (ZERO-Cterm) that is identical to STREX-Cterm except
with the exclusion of the STREX insert (19, 25, 27), was not
palmitoylated by endogenous DHHCs inHEK293 cells and dis-
played a largely cytoplasmic distribution (Fig. 1, b and c). Taken
together, these data demonstrate that the only cysteine residues
within the entire C terminus of the STREX variant of the BK
channel that are endogenously palmitoylated in HEK293 cells
are cysteine residues 12 and 13 within the STREX insert.
Multiple Endogenous DHHCs Control Membrane Expression
of the STREXDomain—In an attempt to addresswhichDHHCs
regulate palmitoylation of the STREX insert, we first examined
the mRNA expression of endogenous DHHCs in our HEK293
cells. Using quantitative real time PCR (qRT-PCR) revealed
expression of all 23 humanDHHCs at themRNA level (Fig. 2, a
and b). In HEK293 cells DHHC4 mRNA was expressed at the
highest level with most other DHHCmRNAs expressed at lev-
els between 5 and 20% of DHHC4.
Based on this mRNA expression profile, we exploited multi-
ple siRNAs against each DHHC isoform to allow us to screen
the effect of knocking down DHHC isoforms on membrane
localization of the STREX domain. For themajority of DHHCs,
we could reliably achieve80% knockdown (i.e.
20% mRNA
remaining) of mRNA as determined by qRT-PCR, using two
siRNAs/DHHC (Fig. 1c). In a few cases (e.g. DHHC 11 and 19),
even using multiple distinct siRNA combinations, we were
unable to achieve mRNA knockdown above 50%. Because anti-
bodies are not available to reliably detectmostDHHC isoforms,
wewere unable tomonitor DHHCprotein levels. Thus tomon-
itor for knockdown efficiency in this system, we transfected
siRNA against GFP to knock down expression of the STREX-
Cterm-GFP fusion protein. Under our transfection conditions,
typically 75% of all cells express the transfected fusion con-
DHHC Palmitoylation of BK Channels
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struct. In the presence of GFP siRNA, less than 2% of all cells
displayed significant GFP expression, indicating that the effi-
ciency of GFP knockdown was97%.
By exploiting this siRNA screen in conjunction with
expression of the CRD-YFP construct (to maximize signal/
noise ratio), we first assayed the contribution of individual
DHHCs to regulate the plasma membrane expression of the
CRD-YFP construct in imaging assays. Individual knock-
down of DHHCs 3, 5, 7, 9, and 17, but none of the other
DHHCs in which high efficiency knockdown could be
achieved resulted in a significant reduction in plasma mem-
brane expression of the CRD-YFP fusion protein in HEK293
cells compared with the control (scrambled siRNA) alone
(Fig. 2d), implicating these DHHCs in STREX palmitoyla-
tion. However, combinatorial knockdown of these DHHCs
did not result in additive effects beyond those seen with the
largest decrease in membrane expression of the CRD-YFP
fusion protein with siRNA against DHHC9 (data not shown).
Combinatorial knockdown was limited by the reduced effi-
ciency of knockdown using multiple siRNAs and was limited
by total siRNA concentrations 100 nM being toxic to cells.
In contrast, inhibition of palmitoyltransferase activity using
FIGURE 1. Endogenous palmitoylation of the BK channel C terminus in HEK293 cells is only conferred by cysteine residues 12 and 13 in the alternatively
splicedSTREX insert.a, schematic illustratinga singlepore-forming-subunit of theSTREX splice variantof theBKchannel. TheSTREX splice insert is localized in the
intracellular linker between the two regulator of potassium conductance (RCK) domains. The STREX insert together with the upstream heme-binding domain
represent the CRD of the linker. Amino acid numbering of the STREX insert starts with the first lysine residue, and cysteine residues 12 and 13 are predicted to be
palmitoylated.b, fluorograph (upper panel) andcorrespondingWesternblot (lower panel) ofHA-taggedC-terminal constructs of theBKchannel expressed inHEK293
cells. The cellswere labeledwith [3H]palmitate (3H-palm) for 4 h, and the constructswere immunoprecipitatedusing anti-HAmagneticmicrobeads. c, representative
single confocal sections and schematics of GFP C-terminal or YFP CRD constructs expressed in HEK293 cells. The scale bars are 5 m. d, quantification of construct
expression at the plasmamembrane expressed as percentages of themembrane expression of the respective STREX-Ctermor CRD fusionprotein. Cells treatedwith
the palmitoyltransferase inhibitor 2-bromopalmitate (2BP) were exposed to 100 M overnight. The data are the means S.E. where N 5 and n 400 for each
construct/condition. **, p
 0.01, comparedwith respective STREX construct by analysis of variancewith post-hoc Dunnett’s test.
DHHC Palmitoylation of BK Channels
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2-bromopalmitate reduced membrane expression of the
CRD-YFP fusion protein to 
10% of control (Fig. 1d).
Knockdown of DHHCs 3, 5, 7, 9, and 17 also significantly
reduced plasma membrane expression of the STREX-Cterm-
GFP fusion protein by50% (Fig. 3, a and b) comparedwith the
scrambled siRNA control. To test whether siRNA knockdown
of DHHCs 3, 5, 7, 9, and 17 in fact regulated palmitoylation
status of the STREX domain, we assayed [3H]palmitate incor-
poration into the STREX-Ctermconstruct. Importantly, siRNA
knockdown of these DHHCs also significantly reduced but did
not completely abolish palmitoylation of the STREX-Cterm
fusion protein (Fig. 3, c and d). Similar reductions in bothmem-
brane expression and palmitoylation were observed when each
individual DHHC was knocked down by siRNA. One possible
explanation is that knockdown of any one of theseDHHCs results
in a compensatory reduction in expression of a common DHHC.
For example, does knockdown of DHHC 3, 5, 7, or 9 also give a
reduced DHHC17 expression? However, at least at the mRNA
level, we sawno significant down-regulation of a commonDHHC
mRNAuponknockingdown individualDHHCs (datanot shown).
Taken together these data suggest that the endogenousDHHCs 3,
5, 7, 9, and 17 are important determinants of the palmitoylation
status of the STREX domain.
DHHC Overexpression Enhances Membrane Expression of
the STREX C Terminus—If endogenous DHHCs 3, 5, 7, 9, and
17 control palmitoylation of the STREX domain, we hypothe-
sized that overexpression of these DHHCs should enhance
plasma membrane localization of the STREX C terminus. We
thus co-expressed the STREX-Cterm-GFP construct with HA-
tagged murine DHHCs (22) and examined the plasma mem-
brane localization of STREX-Cterm-GFP in HEK-293 cells co-
expressing both fusion proteins. To facilitate analysis we
co-expressed constructs and imaged expression 24 h after
expression. Under these conditions STREX-Cterm-GFP mem-
brane localization is typically25% (Fig. 4a) of that seen under
normal conditions when imaging is performed 48 h after trans-
fection as in Figs. 1 and 3. Under these conditions, overexpres-
sion of DHHCs 3, 5, 7, 9, and 17 significantly increased (more
than 2-fold) plasma membrane localization of the STREX-
Cterm fusion protein (Fig. 4b). This stimulatory effect was not
observed in the presence of the palmitoyltransferase inhibitor
2-bromopalmitate (data not shown).
In contrast, overexpression of DHHCs identified in our
siRNA screen because not being involved in endogenous palmi-
toylation of the STREX domain, including those such as
DHHCs 11, 19, and 24 in which siRNA knockdown was
70%,
had no significant effect on STREX-Cterm-GFP expression at
the plasma membrane (Fig. 4c). Furthermore, co-expression of
the catalytically inactive palmitoyltransferase mutants DHHS3
or DHHS7 (22) had no effect on membrane expression, dem-
onstrating that the palmitoyltransferase activity of the DHHCs
is required rather than an effect via a possible chaperone func-
tion (Fig. 4c). To verify that the effect of DHHC overexpression
was dependent upon palmitoylation of the STREX domain
itself, we analyzed the effect of DHHCs 3, 5, 7, 9, and 17 on the
C12A/C13Amutant of the STREX-Cterm fusion protein that is
an absolute requirement for palmitoylation by endogenous
DHHCs and expression at the plasma membrane (Fig. 1, b–d).
Under these conditions membrane expression of the C12A/
C13A fusion alone is almost undetectable (Fig. 4d). Surpris-
ingly, overexpression of DHHCs 3, 5, 7, or 9 also significantly
enhancedmembrane expression of theC12A/C13A fusion pro-
tein to levels that in fact approached that observed upon co-
expression with the wild-type STREX-Cterm-GFP (Fig. 4d). In
contrast, although there was a small effect of DHHC17 to
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FIGURE 2. Multiple endogenous DHHCs control membrane localization of
the STREX domain. a, representative agarose gel of Sybr-safe-stained PCR
amplicons from real time qRT-PCR assays of DHHCs expressed in HEK293 cells
(notenumberingaccording tohumanDHHCconvention, thusnoDHHC10).Mw,
molecular weightmarker. b, relativemRNA expression of each DHHC expressed
as a percentage of DHHC4. c, efficiency of siRNA-mediated knockdown of each
DHHC using two independent siRNAs/DHHC. mRNA levels were quantified by
qRT-PCR, and the mRNA expression remaining, following siRNA-mediated
knockdownof the cognateDHHC,was expressed as a percentage of the respec-
tive control mRNA level for each DHHC. qRT-PCR assays were performed in par-
allel with the imaging assays in d. d, effect of DHHC knockdown on membrane
expression of the CRD-YFP construct expressed in HEK293 cells. The data are
expressedas thepercentageof change inmembraneexpressioncomparedwith
the CRD-YFP construct in the presence of the scrambled siRNA. The data are the
means S.E. whereN 3 and n 350 for each siRNA knockdown. **, p
 0.01,
compared with CRD-YFP construct with scrambled siRNA by nonparametric
KruskalWallis test with post-hoc test.
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increase membrane expression of the C12A/C13A mutant,
expression was still significantly lower (
40%) than that seen
with the STREX-Cterm alone. These data imply that DHHC 17
is likely the most selective DHHC for palmitoylation of cys-
teines 12 and 13 in the STREX domain but also suggest that
additional palmitoylation sites can be engaged by overexpres-
sion of DHHCs to control membrane expression of the C ter-
minus of the STREX BK channel.
Intriguingly, the cysteine residue (Cys16) immediately down-
stream of cysteines 12 and 13 within the STREX domain is also
predicted to be palmitoylated using the CSS-PALM v2.0 algo-
rithm (24). To address whether Cys16 may be a target for over-
expressed DHHCs, we made the triple mutant C12A/C13A/
C16A, in which all three cysteines are mutated to alanine. The
construct was robustly expressed in HEK293 cells but failed to be
located at the plasma membrane as predicted (Fig. 4e). However,
co-expression of any DHHC now failed to enhance plasmamem-
brane localization of the C12A/C13A/C16A construct (Fig. 4e).
Taken together, these data suggest thatDHHC17 ismost selective
for cysteines 12 and 13within STREX but that exogenous overex-
pression of DHHCs 3, 5, 7, or 9 can also regulate palmitoylation
status andmembrane localization via Cys16.
DHHCs Co-immunoprecipitate with STREX BK Channels—
Previous studies have suggested that a number of palmitoylated
proteins can assemble with their
cognate DHHCs (2, 12, 21, 30).
Because multiple DHHCs are able
to control the palmitoylation status
of the STREX domain, we asked
whether DHHCs may be able to
assemble in a complex with the
full-length BK channel. In these
studies full-length STREX chan-
nels with a C-terminal GFP fusion
were co-expressed with HA-
tagged DHHCs in HEK293 cells
and subjected to reciprocal co-
immunoprecipitation assays. Pull-
down using anti-HA antibodies
resulted in robust immunoprecipi-
tation of DHHCs 3, 5, 7, 9, and 17.
Immunoprecipitates were probed
for the GFP tag on the BK channel,
revealing co-immunoprecipitation
with each DHHC (Fig. 5a). Immu-
noprecipitation controls including
cells expressing STREX-GFP chan-
nel alone (Fig. 5, control) or beads
alone (not shown) did not result
in co-immunoprecipitation. Similar
results were observed with the
reciprocal pulldown in which chan-
nels were immunoprecipitated with
anti-GFP and probing for the HA
tag on the respective GFP (Fig. 5b),
except that under these conditions
we could not reliably co-immuno-
precipitate DHHC5.
Knockdown of DHHC3, 5, 7, 9, or 17 Prevents PKA-mediated
Inhibition of the STREX Channel—To address the functional
relevance of STREX domain palmitoylation controlled by
DHHC3, 5, 7, 9, and 17, we examined the functional cross-talk
between the palmitoylation andPKA-dependent phosphorylation
of the STREX channel reported previously (19). Phosphorylation
of the STREX domain by PKA leads to channel inhibition; how-
ever, this inhibition is conditional on the STREX domain being
palmitoylated and associated with the plasmamembrane (19).
In cells treated with the scrambled siRNA, application of
cAMP to the intracellular face of inside-out patches from
HEK293 cells expressing the full-length STREX channel
resulted in robust inhibition of STREX channel activity that is
entirely dependent upon endogenous PKA activity closely asso-
ciated with the channel (19, 25, 27), as reported previously in
control conditions (Fig. 6). However, in cells in which DHHCs
3, 5, 7, 9, or 17 were individually knocked down by siRNA,
cAMP-mediated inhibition of the channelwas completely abol-
ished (Fig. 6). To validate that the lack of cAMP-mediated inhi-
bition of STREX channel activity in cells inwhich theseDHHCs
have been knocked down does not result from disruption of
cAMP-dependent activation of PKA, we also analyzed the
effect of applying the PKAc to the intracellular face of the patch.
Under these conditions application of PKAc in control siRNA
FIGURE3.DHHCs3,5,7,9,and17controlSTREXpalmitoylationandmembraneassociation.a, representative
lowpower confocal sections of HEK293 cells expressing the STREX-Cterm-GFP fusion protein and transfectedwith
siRNA against the indicated DHHC. The scale bars are 20 m. b, quantification of STREX-Cterm-GFP membrane
localization, expressed as a percentage of the membrane localization with the scrambled siRNA, following the
respectiveDHHC knockdown. The data are themeans S.E. whereN 4 and n 350 for each siRNA knockdown.
c, fluorograph(upperpanel)andcorrespondingWesternblot (lowerpanel)ofHA-taggedC-terminalconstructsofthe
BKchannelexpressed inHEK293cells. Thecellswere labeledwith [3H]palmitate (3H-palm) for4h,andtheconstructs
were immunoprecipitatedusinganti-HAmagneticmicrobeads.d, quantificationof STREX-Ctermpalmitoylation follow-
ingsiRNAknockdownofDHHCsbysiRNAas inc. Thedataareexpressedaspercentagesofpalmitate incorporationinthe
STREX-Ctermconstruct inscrambledsiRNA-treatedcells. Thedataare themeansS.E.,N3–4. *,p
0.05; **,p
0.01,
comparedwith respective scrambledcontrolgroupbyanalysisof variancewithpost-hocDunnett’s test.
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transfected cells inhibited STREX channel activity by 68 8%,
n  7. In contrast, in cells in which DHHC17 was knocked
down by siRNA, no significant change in activity was observed
(mean change in activity was 10.8 8.3%, n 5). Thus knock-
down of any of the DHHCs implicated in regulating palmitoy-
lation of the STREX domain also controls the regulation of
STREX channels by PKA-mediated phosphorylation.
DISCUSSION
Our data provide the first systematic analysis of the role of indi-
vidual DHHC palmitoyltransferases in the palmitoylation and
regulation of a voltage-gated ion
channel. We demonstrate that the
intracellular alternatively spliced
STREX domain of BK channels is
endogenously palmitoylated by mul-
tiple palmitoyltransferases (DHHCs).
Using siRNA knockdown, DHHCs 3,
5, 7, 9, and 17 were all shown to con-
trol STREX domain palmitoylation
and association of the STREX C ter-
minus with the plasma membrane.
Importantly, knockdown of these
DHHCs also controlled PKA-depen-
dent inhibition of the STREX BK
channel that we have previously
shown to be the major functional
effect of palmitoylation of STREX in
BK channels (19).
Previous analysis of ligand-gated
ion channels has revealed an impor-
tant role for DHHC3 (also known
as GODZ) in controlling channel
palmitoylation (6, 7, 10, 12, 30).
DHHC3 is rather promiscuous in its
palmitoylation of target proteins
(21, 22, 31), and DHHC3 controlled
palmitoylation of STREX. DHHC7,
which may heteromultimerize with
DHHC3 (10), was also implicated in
STREX palmitoylation. In addition
DHHC9, DHHC5, and DHHC17
also controlled STREX palmitoyla-
tion and function. The regulation of
STREX by DHHC17 is particu-
larly intriguing because DHHC17 is
also reported to palmitoylate other
cysteine-rich proteins including
SNAP25 (32), cysteine string pro-
tein (33), and huntingtin (34). Over-
expression assays suggested that
DHHC17 has the highest selectivity
for the palmitoylated dicysteine
motif of STREX (cysteines 12 and 13
in STREX). Taken together, because
Cys12-Cys13 falls within a cysteine-
rich domain, as a result of inclusion
of the alternatively spliced STREX
exon, this may suggest that DHHC17may preferentially palmi-
toylate cysteine residues within internal cysteine-rich domains
of proteins.
The ability of multiple DHHCs to target the same protein
appears to be a general recurring theme in protein palmitoyla-
tion.However, it is somewhat surprising that knockdownof any
one of these DHHCs (3, 5, 7, 9 or 17) has very similar effects on
palmitoylation status, membrane association, and the ability to
prevent PKA-mediated inhibition of STREX channels. Indeed,
although our attempts to simultaneously knock down all of
these DHHCs was unsuccessful, there was no significant addi-
FIGURE 4. DHHC overexpression enhances membrane localization of STREX-Cterm. a, representative low
power confocal sections of HEK293 cells 24 h after transfection with STREX-Cterm-GFP (left-hand panels) or co-
transfectedwith DHHC17 (right-hand panels). Under each condition the STREX-Cterm-GFP localization andHA tag
imageplanes are shown. The scale bars are 10m.b and c, quantificationof STREX-Cterm-GFP.d and e, C12A/C13A
(d) andC12A/C13A/C16A (e)membrane localization in cells co-expressing the correspondingDHHC, or the inactive
mutant (DHHS). In b–e, the data are expressed as percentages of STREX-Cterm-GFP membrane localization
observed in the absence of overexpressed palmitoyltransferase (100%, dashed line). The data are themeans S.E.
whereN5andn400foreachgroup.*,p0.05; **,p
0.01,comparedwiththeSTREX-Cterm-GFPconstruct in the
absence of overexpressed palmitoyltransferase by analysis of variancewith post-hoc Dunnett’s test.
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tive effect onmultiplexing siRNAknockdown.Multiple distinct
mechanisms may be involved in this effect, resulting in each
DHHC having an effect in controlling palmitoylation and func-
tion, as has been suggested with other proteins. For example, it
may simply reflect that the normal cellular expression of each of
these DHHCs is required for efficient palmitoylation as the
channel traffics to the plasma membrane. It may also reflect
potential different localization of specific DHHC substrate
interactions occurringwithin the trafficking pathway. Thismay
be particularly important for tetrameric proteins like BK chan-
nels such that a combinatorial code of palmitoylation on mul-
tiple sites across multiple subunits is important for the overall
palmitoylation status and functional effect. For example, eight
cysteine residues (i.e. 4 Cys12 and Cys13 in STREX) would be
available for palmitoylation in the tetrameric homomeric chan-
nel. Although the majority of DHHCs that control STREX
palmitoylation are thought to beGolgi/endoplasmic reticulum-
localized upon overexpression (23), the localization of endoge-
nous DHHCs and their potential trafficking is poorly under-
stood because of the lack of available antibodies to characterize
many of the endogenous DHHC proteins. Additional mecha-
nisms may also exist. As already discussed, heteromultimeriza-
tion of DHHCs may occur as previously demonstrated using
overexpressed DHHC3 and DHHC7 (10), or the activity/local-
ization of DHHCs may themselves be controlled by palmitoy-
lation as has been shown for autopalmitoylation of some
DHHCs (2). However, the extent to which other DHHCs het-
eromultimerize, the role of heteromultimerization, and the
FIGURE 5.DHHCs 3, 5, 7, 9, and 17 co-immunoprecipitatewith full-length
STREX BK channel. Western blots of co-immunoprecipitated HA-tagged
DHHCs with GFP-tagged full-length STREX BK channels expressed in HEK293
cells. In a, DHHCs were immunoprecipitated (IP) with anti-HA magnetic
microbeads, and in b, channels were immunoprecipitated using anti-GFP
magneticmicrobeads, and immunoprecipitateswere subjected to SDS-PAGE
and transferred to polyvinylidene difluoride. The immobilon and the respec-
tive tag were probed and detected by enhanced chemiluminescence.
FIGURE 6.DHHCknockdownprevents PKA-mediated inhibition of STREX
channels. a, representative single channel traces from excised inside-out
patches of HEK293 cells expressing full-length STREX BK channels before and
5 min after exposure to cAMP. Left- and right-hand panels are from cells co-
transfected with scrambled and DHHC17 siRNA, respectively. Patches were
held at 40 mV in physiological potassium gradients with intracellular free
calcium buffered to 0.1 M in the presence of 2 mM Mg-ATP. b, summary bar
chart of the effect of cAMP on STREX single channel open probability (Po)
expressed as the percentage of change in activity from pre-cAMP control
under each condition. Thedata are themeans S.E.,N 6–10/group. **, p

0.01, compared with the scrambled siRNA group by nonparametric Kruskal
Wallis test with post-hoc test.
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functional effect of DHHC palmitoylation in native systems are
largely unknown.
An additional factor that may also be important is the stoi-
chiometry of BK channel palmitoylation that is required for the
functional effects of palmitoylation to be manifest. In this
regard, we have previously shown that phosphorylation of only
a single STREXdomain in the channel tetramer is important for
functional regulation (25). Whether this is also the case for
palmitoylation remains to be determined.
Increasing evidence suggests that DHHCs may assemble
with their target substrates. For example, DHHC3 and 17
assemble with SNAP25 (21), whereas DHHC3 has been shown
to form a complex with -aminobutyric acid, type A and
-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate recep-
tors (12, 30). Our data reveal that, at least in overexpression
systems, the cognate DHHCs that palmitoylate the STREX
domain also can assemble as a complex with the channel.
Clearly whether the interaction is direct or results from assem-
bly as amuch largermacromolecular complex in native systems
warrants further investigation. Furthermore, whether cycles of
palmitoylation/depalmitoylation are required as the channels
traverse different stages in the pathway leading to delivery to
the cell surface remains to be explored.
Intriguingly, overexpression of DHHCs that endogenously
control STREX palmitoylation (apart from DHHC17) also
allowed access of these DHHCs to a cysteine residue (Cys16)
immediately downstream of the Cys12-Cys13 site. This implies
that Cys16 may also be a target for palmitoylation in some cell
types in which these DHHCs have access to the site, thus
extending the potential repertoire by which STREX channels
may be regulated by palmitoylation.However, no other cysteine
residues within the entire C terminus of the channel were tar-
gets for palmitoylation in HEK293 cells because mutation of
Cys12-Cys13 completely abolished palmitate incorporation by
endogenous DHHCs.
In conclusion, our work reveals that DHHCs 3, 5, 7, 9, and 17
are important determinants of STREX BK channel palmitoyla-
tion, STREX domain interaction with the plasma membrane,
and functional regulation. Our approach thus represents the first
systematic analysis of ion channel palmitoylation by the multi-
member DHHC family of palmitoyltransferases. Our strategy
employing both loss and gain of function strategies and utilizing
fluorescent fusion proteins to screen for the effects of palmitoyla-
tion of plasmamembrane expression of palmitoylated domains of
transmembrane proteins may serve as an approach to further
interrogate the specificity and role of DHHCs in controlling ion
channel and other plasma membrane transmembrane protein
regulation by protein palmitoylation.
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